Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Aspergillus infection? 305 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Aspergillus infection have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.4% of all adverse event reports for DOXORUBICIN.

305
Reports of Aspergillus infection with DOXORUBICIN
0.4%
of all DOXORUBICIN reports
148
Deaths
147
Hospitalizations

How Dangerous Is Aspergillus infection From DOXORUBICIN?

Of the 305 reports, 148 (48.5%) resulted in death, 147 (48.2%) required hospitalization, and 84 (27.5%) were considered life-threatening.

Is Aspergillus infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 305 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Aspergillus infection?

PREDNISONE (1,231) TACROLIMUS (1,099) RITUXIMAB (952) MYCOPHENOLATE MOFETIL (888) METHOTREXATE (828) METHYLPREDNISOLONE (788) DEXAMETHASONE (785) CYCLOPHOSPHAMIDE (733) ETOPOSIDE (676) PREDNISOLONE (667)

Which DOXORUBICIN Alternatives Have Lower Aspergillus infection Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Aspergillus infection Reports All Drugs Causing Aspergillus infection DOXORUBICIN Demographics